Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05986851
Title Azeliragon in MGMT Unmethylated Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cantex Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 United States Details
Miami Cancer Institute - Baptist Health Miami Florida 33176 United States Details
Corewell Health Royal Oak Michigan 48073 United States Details
Washington University in St. Louis Saint Louis Missouri 63110 United States Details
Lenox Hill Hospital New York New York 10021 United States Details
The University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 United States Details
University of Utah Health Huntsman Cancer Center Salt Lake City Utah 84112 United States Details
University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field